Literature DB >> 12629075

A case report in favor of a multistep adrenocortical tumorigenesis.

Marie-Hélène Bernard1, Stan Sidhu, Nicole Berger, Jean-Louis Peix, Deborah J Marsh, Bruce G Robinson, Véronique Gaston, Yves Le Bouc, Christine Gicquel.   

Abstract

The mechanisms of adrenocortical tumorigenesis are still not fully understood. Data from clonal analysis, comparative genomic hybridization, and allelotyping suggest that it involves a multistep process during which several genetic defects are progressively acquired, leading to the malignant transformation. The events involved in the first steps of this process are not well known, and most of the abnormalities described in adrenocortical tumors to date are associated with the malignant phenotype. We report a case that suggests that adrenocortical tumorigenesis may be a multistep process. A 43-yr-old patient underwent surgery for an incidentally discovered adrenal mass. Pathological analysis showed that this tumor consisted of two parts: a central part with features of malignancy surrounded by another part with a strictly benign appearance. These data were confirmed by molecular analysis and comparative genomic hybridization that were consistent with either a malignant or benign presentation. The apparently malignant part of the tumor exhibited molecular abnormalities [17p13 loss of heterozygosity (LOH), 11p15 uniparental disomy and overexpression of the IGF-II gene] as well as chromosomal gains and losses (comparative genomic hybridization) that have been previously described in malignant tumors. No abnormalities were found in the surrounding benign tissues. Although this observation is not definitive proof that adrenocortical tumorigenesis occurs via a multistep process, it suggests that there is a progressive change from the benign to the malignant state in some adrenocortical tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629075     DOI: 10.1210/jc.2002-021117

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.

Authors:  Joanne H Heaton; Michelle A Wood; Alex C Kim; Lorena O Lima; Ferdous M Barlaskar; Madson Q Almeida; Maria C B V Fragoso; Rork Kuick; Antonio M Lerario; Derek P Simon; Ibere C Soares; Elisabeth Starnes; Dafydd G Thomas; Ana C Latronico; Thomas J Giordano; Gary D Hammer
Journal:  Am J Pathol       Date:  2012-07-15       Impact factor: 4.307

2.  Improvement of histopathological classification of adrenal gland tumors by genetic differentiation.

Authors:  Torsten Gruschwitz; Jan Breza; Heiko Wunderlich; Kerstin Junker
Journal:  World J Urol       Date:  2010-04-03       Impact factor: 4.226

Review 3.  Adrenocortical tumorigenesis: Lessons from genetics.

Authors:  Crystal D C Kamilaris; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-05-23       Impact factor: 4.690

4.  Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors.

Authors:  Mauro Papotti; Eleonora Duregon; Marco Volante; Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

5.  Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathways.

Authors:  Cristina L Ronchi; Ellen Leich; Silviu Sbiera; Dirk Weismann; Andreas Rosenwald; Bruno Allolio; Martin Fassnacht
Journal:  Neoplasia       Date:  2012-03       Impact factor: 5.715

6.  Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.

Authors:  Liem M Phan; Enrique Fuentes-Mattei; Weixin Wu; Guermarie Velazquez-Torres; Kanishka Sircar; Christopher G Wood; Tao Hai; Camilo Jimenez; Gilbert J Cote; Levent Ozsari; Marie-Claude Hofmann; Siyuan Zheng; Roeland Verhaak; Lance Pagliaro; Maria Angelica Cortez; Mong-Hong Lee; Sai-Ching J Yeung; Mouhammed Amir Habra
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

Review 7.  New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2008-11-21       Impact factor: 4.102

Review 8.  Genetics and epigenetics of adrenocortical tumors.

Authors:  Antonio M Lerario; Andreas Moraitis; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2013-11-09       Impact factor: 4.102

Review 9.  Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.

Authors:  Ronald R de Krijger; Thomas G Papathomas
Journal:  Virchows Arch       Date:  2011-11-16       Impact factor: 4.064

10.  Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypes.

Authors:  Maryline Herbet; Aude Salomon; Jean-Jacques Feige; Michaël Thomas
Journal:  PLoS Genet       Date:  2012-05-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.